Company Profile

Remedium Technologies Inc
Profile last edited on: 1/18/20      CAGE: 5H1B0      UEI: HFL9S8BZK9N5

Business Identifier: Trauma medicine for treating severe hemorrhage
Year Founded
2007
First Award
2011
Latest Award
2018
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

387 Technology Drive 3110B
College Park, MD 20742
Location: Single
Congr. District: 05
County: Prince Georges

Public Profile

Remedium Technologies Inc is a medical device start-up operating with a vision of user-directed advancement in the standard of care for the control of severe hemorrhage. Severe hemorrhage is the leading cause of death on the battlefield, accounting for over half of all preventable deaths in combat, while within the civilian setting, traumatic injuries are the leading cause of death among patients under the age of 44. Currently available products or methods to stop these kinds of injuries are either inherently ineffective or very difficult for most users to implement effectively. The principals of Remedium Technologies have created a proprietary life-saving technology called Hemogrip which acts to stop traumatic bleeding rapidly. Hemogrip is a uniquely user-friendly hemostat which is able to orchestrate the self-assembly of a clot-like seal upon contact with blood. It can be used effectively by a surgeon, by a soldier, or by an unskilled “buddy.â

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2018 2 NSF $1,125,999
Project Title: Sprayable Reversible Hemostat for Treatment of Non-Compressible Hemorrhage

Key People / Management

  Matthew Dowling -- Chief Executive Officer; Co-Founder

  Tim Askew -- Vice President of Business Development